Trial intelligence / Profile preview

Tacrolimus for severe infertility patients undergoing embryo transfer

jRCTs031220235Completed

Sponsor
Japan Agency for Medical Research and Development
Start
May 2023
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of tacrolimus in infertility, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Confirmation of fetal sac. Started May 2023; status: completed.

02

Drugs

tacrolimus
03

Conditions

infertility

Beyond the preview

Go deeper on jRCTs031220235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call